FOLLOW US

Endocrine Research Updates

For Medical Professionals

Instead of suppressing the immune system, this new approach engages it
Instead of suppressing the immune system, this new approach engages it
The pump system has proved to improve the length of time users spend in ideal gl
The pump system has proved to improve the length of time users spend in ideal glucose range
Oral therapy for acromegaly solves logistical problems and is not associated wit
Oral therapy for acromegaly solves logistical problems and is not associated with the discomfort of injectable drugs
Patients report that being told by doctors that they have a 'good cancer' invali
Patients report that being told they have a good cancer invalidates their fears and creates mixed and confusing emotions
A new study shows that GLP-1 and SGLT2i drug classes have protective effects
A new study shows that GLP-1 and SGLT2i drug classes have protective effects
Rate of hypothyroidism are double in those working the longest hours
Rates of hypothyroidism are double in those working the longest hours
A new way to lower medical costs for patients with diabetes
A new way to lower medical costs for patients with diabetes
The new drug is a game changer for patients with TED
The new drug is a game changer for patients with TED
The first drug specifically for the treatment of thyroid eye disease has been approved by the FDA.
Feet wearing Chuck Taylors standing at the base of diverging arrows
More than 80 percent of patients had diabetes remission within 5 years of surgery
Benefits of a sleeve gastrectomy versus gastric bypass surgery.
For patients with diabetes, dental hygiene is even more important
For patients with diabetes, it is even more important to remember the relationship between oral health and general health

For patients with diabetes, it is even more important to remember the relationship between oral health and general health

Timing is the critical factor in whether steroids help or harm COVID-19 patients
Timing is crucial when considering steroids in patients with COVID-19 and an endocrine disorder.
In reviewing key trial findings, the Food and Drug Administration has granted approval to drugs that promise better glucose control or lipid-lowering efficacy.
Lorcaserin has been recalled for concerns about elevated cancer risk.
Oral testosterone for adult men with androgen deficiency available, cancer concerns over lorcaserin, and push to bring more biosimilars to market.
The effects of antibiotic use on body weight are evaluated based on use during pregnancy and into the first 4 years of life with findings of a modest, dose-dependent association.
Drug increased brown fat which revs up metabolic effects..
Introducing a beta3-AR agonist, mirabegron, shows increases in energy expenditure, insulin sensitivity, and improved levels of circulating fats, according to ongoing research at the NIH.
Hyperthyroidism appears associated with development of dementia.
Graves’ disease and toxic nodular goiter increase the odds that these patients will develop dementia, including Alzheimer’s disease and vascular dementia, a relationship perhaps driven by prolonged low TSH.
People should get tested for Lp(a) levels at least once to rule out CVD risk.
A strong case is made for testing lipoprotein(a) levels at least once early in life to ascertain future risk of coronary artery disease.
With all the upsides, how often are you actively implementing a management care plan for the many at-risk patients that present in your practice?
close X
SHOW MAIN MENU
SHOW SUB MENU